InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Dawes Karen A, Director. Director active across 3 companies, notably Vaccitech plc. In total, 21 filings have been logged. Breakdown: 1 buy · 7 sells. Total volume traded: €864k. History available since 4 May 2021. The latest transaction was filed on 17 December 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Dawes Karen A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
275 shares@ US$161.003.3% of flowCommon StockSEC:0001193125-25-324912:0
973 shares0Common StockSEC:0000950170-25-074251:0
2,953 shares@ US$67.7113.7% of flowCommon StockSEC:0000950170-24-073829:0
803 shares0Common StockSEC:0000950170-24-062599:0
4,626 shares@ US$42.0713.2% of flowCommon StockSEC:0000950170-24-022581:0
7,392 shares@ US$18.129.1% of flowCommon StockSEC:0000950170-23-045417:0
798 shares0Common StockSEC:0000899243-23-013671:0
775 shares@ US$227.1713.0% of flowCommon StockSEC:0000899243-22-030728:0
644 shares0Common StockSEC:0000899243-22-020280:0
2,576 shares@ US$149.180.0062% mcap31.8% of flowCommon StockSEC:0000899243-22-019772:0
4,783 shares@ US$26.120.0019% mcap9.5% of flowCommon StockSEC:0000899243-21-044418:0
64 shares@ US$299.021.6% of flowCommon StockSEC:0000899243-21-043038:0
13 shares@ US$290.020.3% of flowCommon StockSEC:0000899243-21-036134:0
3,459 shares@ US$38.7611.0% of flowCommon StockSEC:0000899243-21-034897:0
924 shares@ US$251.1519.3% of flowCommon StockSEC:0000899243-21-033643:0
2,929 shares@ US$41.190.0018% mcap9.1% of flowCommon StockSEC:0000899243-21-029533:0
288 shares@ US$200.014.8% of flowCommon StockSEC:0000899243-21-029561:0
2,929 shares@ US$41.1910.0% of flowCommon StockSEC:0000899243-21-028505:0
604 shares0Common StockSEC:0000899243-21-019705:0
15,000 shares@ US$3.223.5% of flowCommon StockSEC:0000899243-21-019419:0
1,700 shares@ US$17.00100.0% of flowOrdinary SharesSEC:0001104659-21-062434:0
Canonical exit: 2 Aug 2021 (T+90)
21 of 21 declarations
About Dawes Karen A
DAWES KAREN A is a Director at Repligen CORP, REPLIGEN CORP and Vaccitech plc. She has 21 filings in total, and across the sampled recent filings the buy and sell amounts are EUR 24053 and EUR 839878, with filings dated from 2021-05-06 to 2025-12-18. The modal transaction nature is Option exercise.
